← Browse by Condition
Medical Condition

extramedullary multiple myeloma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06140966 Phase 2
Recruiting

Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma

Enrollment
54 pts
Location
China
Sponsor
Union Hospital, Tongji Medical...
View Trial →